
The Republic of Azerbaijan is located in one of the regions of the world with the richest veg-etation cover – the Caucasus. The country's territory is geographically divided into 25 geobotan-ical regions. According to the latest data, more than 5.000 species of plants are found on the ter-ritory of Azerbaijan. The purpose of this article is to study the prospects for the use of wild plants in the field of pharmacy, analyze them by species and genera, and identify scientific di-rections for future researchers. Recently, the demand for vegetable raw materials on the world market has been constantly increasing. With this in mind, based on the book "Flora of Azerbaijan", 191 genera and 1075 species of plants belonging to 61 families have been identified, promising for study in the phar-macognostic aspect. As a result of studying promising plant species, new natural sources of bio-logically active compounds will be discovered and effective medicines based on them will be created. Plant raw materials for industrial production and export will be identified, as well as new officinal medicinal plants will be discovered. Based on the results of studying the chemical composition of plants, chemotaxonomic patterns for the corresponding genera and species will be determined. By determining the distribution areas and raw materials of wild medicinal plants and recording the results on maps, the book "Atlas of areas and reserves of raw materials of wild medicinal plants of the Republic of Azerbaijan" will be published. The study and use of waste generated in areas where plant raw materials are used will help support the country's economy and improve the environmental situation of the region.
The modern era, when antimicrobial resistance has become a global problem, is accompanied by increasing of the infections, caused by resistant microorganisms. The obtaining of new anti-microbial agents is one of the main direction against antimicrobial resistance. Although hundreds of antimicrobial agents have been discovered, only a small number of them are used in medi-cine. It is important to obtain antimicrobial agents based on substances with a new mechanism of action and without the toxic effect. In this regard, a new amino acid based biologically active substance - N-acylamino acid is ob-tained semi-synthetically, was studied. The antimicrobial activity, including the minimum inhibi-tory concentration (MIC) of this substance against the strains of Escherichia coli ATCC®25922™, Staphylococcus aureus ATCC®29213™, Klebsiella pneumoniae ATCC®700603™, Pseudomonas aeruginosa and Candida albicans was evaluated. It was found that the N-acylamino acid exerts an antimicrobial effect on bacteria at low con-centrations. Its MIC for E.coli and K.pneumoniae is 12.5 μg/ml, and for S.aureus and P.aeruginosa is 6.25 μg/ml. This substance does not exhibit antimicrobial activity against C.albicans. Possible mechanisms of the antimicrobial action of the N-acylamino acid are dis-cussed.
Aim of the work: Analysis of proton pump inhibitors by high-performance liquid chromatography. Materials and methods. The studies were conducted on the following comparison standard samples and drugs. Standard samples: omeprazole (working standard Lot: B636472_01), pantoprazole (working standard: PANTBP/2023/01), dexlansoprazole (working standard: RLP/0890922). The following drugs were analyzed in the study: Omeprazole 20 mg capsule N30, Pantoprazole 20 mg tablet N28, Dexlansoprazole 30 mg capsule N30. Acetonitrile (Sigma-Aldrich series: I1306730339), triethylamine (Sigma-Aldrich series: S6010152947), 85% phosphoric acid (Merck KGaA, series: K52615773 029) and ultrapurified water were used as working solvents. Results: The identity and quantity of the main active components included in the composition of omeprazole, pantoprazole and dexlansoprazole preparations were determined by the HPLC method. Optimal chromatographic conditions for the determination of the amount of HPLC in all three preparations were developed and prepared, and the wavelength of 285 nm, injection volume of 10 μl, temperature of 25°C, flow rate of 1.0 ml/min and “Purospher Star RP-8 endcapped” (4.6 x 150 mm, particle size 5 μm) column were determined to be optimal. The proposed method is distinguished by its accuracy, simplicity and short implementation time. The method allows for effective quality control of preparations during their production and use.
The article presents the results of the use of immunological and instrumental diagnostic methods, as well as surgical treatment in 92 patients with recurrent liver echinococcosis. Postop-erative complications were detected in 15 (16.1%) patients, postoperative lethality was observed in 1 (1.07%) cases. As a result of the analysis of the study of immunological tests, it was shown that immuno-chemiluminescence (ICL) and enzyme immunoassay (ELISA) is a highly informative test for the diagnosis of recurrent echinococcosis. The effectiveness of surgical treatment of recurrent echinococcosis is directly dependent on the choice of access, indications for various methods of operations, methods of disinfection and complete elimination of the residual cavity of the fibrous capsule. Chemotherapy with the antihelminthic drug zendox in the distant time after surgery from 6 months to 5 years showed a significant ( P˂0.05) 2.5-fold decrease in the incidence of recurrent hepatic echinococcosis.
Malaria is the main cause of death in tropical and subtropical countries, killing more than 1 million people worldwide each year. Although there are now effective methods to control malaria, the number of malaria cases is still increasing due to several factors. In this emergency, prompt and effec-tive diagnostic and treatment methods are essential for fighting and controlling malaria.Two groups were used for the purpose of research. The standard treatment was held in the first group (3 days), and the prolonged treatment (5 days) - in the second group. All cases with severe malaria course ended by recovery, while besides chemical therapy 33 (94.3%) patients received intravenous desintoxication therapy. Fever duration at the stationary was 3.80±0.42 days, which was longer than chemical therapy. Subfebrilitet duration was observed up to 4 days at the post-fever period in 3 (8.6%) patients. Most of all, asthenic syndrome was observed on average for 17.20±1.49 days in 30 (85.7%) patients during discharging from stationary. The duration of intoxication, complication development, and asthenic syndrome was a reason for a longer period of hospitalization - 18.30±1.39 days. The main treatment of malaria vivax is still chloroquine, which was received by 98.2% of patients. The extension of the treatment course with chloroquine up to 5 days allowed for avoiding the development of earlier re-lapse in the control group.